MetLife Investment Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$11.7M Sell
149,281
-8,685
-5% -$679K 0.07% 271
2025
Q1
$11.4M Sell
157,966
-3,313
-2% -$240K 0.06% 298
2024
Q4
$11.9M Sell
161,279
-475
-0.3% -$35.2K 0.06% 219
2024
Q3
$10.7M Sell
161,754
-4,182
-3% -$276K 0.06% 246
2024
Q2
$15.3M Sell
165,936
-881
-0.5% -$81.4K 0.09% 166
2024
Q1
$15.9M Sell
166,817
-5,137
-3% -$491K 0.11% 150
2023
Q4
$13.1M Sell
171,954
-3,379
-2% -$258K 0.09% 167
2023
Q3
$12.1M Sell
175,333
-3,537
-2% -$245K 0.09% 164
2023
Q2
$16.9M Sell
178,870
-5,333
-3% -$503K 0.12% 132
2023
Q1
$15.2M Sell
184,203
-240
-0.1% -$19.9K 0.11% 138
2022
Q4
$13.8M Sell
184,443
-4,103
-2% -$306K 0.1% 151
2022
Q3
$15.6M Sell
188,546
-2,596
-1% -$215K 0.13% 126
2022
Q2
$18.2M Sell
191,142
-4,689
-2% -$446K 0.14% 120
2022
Q1
$23.1M Buy
195,831
+59,467
+44% +$7M 0.15% 109
2021
Q4
$17.7M Sell
136,364
-2,399
-2% -$311K 0.15% 118
2021
Q3
$15.7M Sell
138,763
-3,342
-2% -$378K 0.14% 121
2021
Q2
$14.7M Sell
142,105
-4,693
-3% -$486K 0.13% 132
2021
Q1
$12.3M Sell
146,798
-2,537
-2% -$212K 0.11% 151
2020
Q4
$13.6M Sell
149,335
-6,254
-4% -$571K 0.13% 137
2020
Q3
$12.4M Sell
155,589
-5,116
-3% -$408K 0.14% 139
2020
Q2
$11.1M Sell
160,705
-581
-0.4% -$40.2K 0.13% 151
2020
Q1
$10.1M Sell
161,286
-4,935
-3% -$310K 0.14% 138
2019
Q4
$12.9M Sell
166,221
-3,567
-2% -$277K 0.13% 142
2019
Q3
$12.4M Sell
169,788
-2,625
-2% -$192K 0.14% 143
2019
Q2
$10.6M Sell
172,413
-4,779
-3% -$294K 0.11% 164
2019
Q1
$11.3M Sell
177,192
-2,166
-1% -$138K 0.12% 154
2018
Q4
$9.16M Sell
179,358
-3,378
-2% -$172K 0.11% 169
2018
Q3
$10.6M Sell
182,736
-3,411
-2% -$198K 0.11% 168
2018
Q2
$9.03M Sell
186,147
-3,465
-2% -$168K 0.11% 172
2018
Q1
$8.82M Sell
189,612
-6,819
-3% -$317K 0.1% 178
2017
Q4
$7.38M Buy
+196,431
New +$7.38M 0.08% 222